Aileen Duffton

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial

Douglas Brand, Alison Tree, Peter Ostler et al. · The Lancet Oncology · 2019 · 519 citations · Full text

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

Alison Tree, Peter Ostler, H. van der Voet et al. · The Lancet Oncology · 2022 · 280 citations · Full text

The potential clinical benefit of respiratory gated radiotherapy (RGRT) in non-small cell lung cancer (NSCLC)

R. Muirhead, C. Featherstone, Aileen Duffton et al. · Radiotherapy and Oncology · 2010 · 39 citations

Radiation Therapy, Medicine, Potential Clinical Benefit +6

Advanced practice: An ESTRO RTTC position paper

Aileen Duffton, Lynsey Devlin, Y. Tsang et al. · Technical Innovations & Patient Support in Radiation Oncology · 2019 · 39 citations · Full text

Intensity-modulated Radiotherapy for Rectal Cancer in the UK in 2020

Catherine Hanna, Finbar Slevin, Ane Appelt et al. · Clinical Oncology · 2021 · 34 citations · Full text